George D. Maynard

2-Substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity

Douglas G. Batt, George D. Maynard, Joseph J. Petraitis et al. · Journal of Medicinal Chemistry · 1990 · 67 citations · Full text

Medicinal Chemistry, Anti-inflammatory, Biochemistry +14

[3.3] Sigmatropy within 1-vinyl-2-alkenyl-7,7-dimethyl-exo-norbornan-2-ols. The first atropselective oxyanionic Cope rearrangement

Leo A. Paquette, Neil Pegg, Dana S. Toops et al. · Journal of the American Chemical Society · 1990 · 60 citations

Cross-coupling Reaction, Molecular Sciences, Engineering +11

Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury

Xingxing Wang, Tianna Zhou, George D. Maynard et al. · Brain · 2020 · 54 citations · Full text

Nogo Receptor Decoy, Neuromodulation Therapies, Neurological Progress +29

Relevance of oxyanion stereochemistry to chirality transfer in anionic oxy-Cope rearrangements

Leo A. Paquette, George D. Maynard · Journal of the American Chemical Society · 1992 · 43 citations

Anionic Oxy-cope Rearrangements, Cross-coupling Reaction, Chemical Measurement +14

Rescue of Transgenic Alzheimer’s Pathophysiology by Polymeric Cellular Prion Protein Antagonists

Erik C. Gunther, Levi M. Smith, Mikhail A. Kostylev et al. · Cell Reports · 2019 · 37 citations · Full text